The unprecedented speed with which COVID-19 vaccines have been developed and approved reflects increasingly nimble trial procedures, but opportunities exist for greater collaboration. Gary Humphreys and Lynn Eaton report.
No takes yet. Share an insight, caveat, or question.
Humphreys et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: